xuan chen

Dr. xuan chen

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

7 July 2014 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
XCxuan chen
xuan chen
ZHZhen Huang
Zhen Huang
WRWenhua Ran
Wenhua Ran
GLGang Liao
Gang Liao
LZLang Zha
Lang Zha
ZWZiwei Wang
Ziwei Wang
Type 2 diabetes mellitus (T2DM) is a prevalent disease worldwide and during its conventional treatment, vascular complications remain unavoidable. Roux‑en‑Y gastric bypass (GBP) is able to induce the remission of T2DM. However, studies of duodenal‑jejunal bypass (DJB), a modified procedure of GBP, are being carried out to investigate its ability to induce the remission of T2DM and protect the aorta from atherosclerosis. The present study aimed to investigate the effect of DJB on the rate of T2DM remission and the prevention of atherosclerosis in the aorta in rats with streptozotocin‑induced diabetes without obesity, and to explore the mechanism of DJB in protecting the aorta from atherosclerosis. A T2DM rat model was established with a high‑fat diet and low‑dose streptozotocin. Surgery was performed to analyze its effects on glucose homeostasis, lipid metabolism, inflammation and pathological changes. Furthermore, changes in c‑jun NH2‑terminal kinase 1 (JNK1) and inhibitor of κB kinase (IKKβ) genes in the aorta following DJB surgery were examined. Levels of blood glucose, lipids, insulin and tumor necrosis factor (TNF)‑α were significantly elevated in the T2DM diabetic model compared with the non‑diabetic control. A gradual recovery was observed in the DJB group following surgery. Foam cells and atherosclerotic plaques appeared in the ascending aortic tissue in the sham‑surgery and T2DM groups, whereas only slight lesions were observed in the DJB group. The expression levels of JNK1 and IKKβ genes in the aorta were significantly increased in the sham‑operated and T2DM groups compared with those in the DJB and normal control groups. The present study demonstrated that DJB caused remission of T2DM without weight loss in non‑obese rats. Thus, DJB may delay or prevent the occurrence and development of atherosclerosis in the aorta and this may occur through the JNK1 and nuclear factor κB (NF‑κB) signaling pathways.

30 November 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
TJTAO JIANG
TAO JIANG
NJNili Jiang
Nili Jiang
XCxuan chen
xuan chen
ZXZuming Xiong
Zuming Xiong
5-Methylcytosine (m5C) methylation is a widely present nucleic acid modification in various RNAs and is a reversible epigenetic modification that affects RNA stability, nuclear export, and translation processes. Methylation writers are responsible for adding methyl groups to RNA molecules, regulating gene expression and cellular function through catalyzing methyl transfer reactions. In order to more intuitively demonstrate the important value of NOL1/NOP2/SUN domain (NSUN) family genes in both tumor and non-tumor diseases, we conducted a relevant review. The NSUN family genes (NSUN1/NOP2, NSUN2, NSUN3, NSUN4, NSUN5, NSUN6, NSUN7) are the main writers of m5C methylation. These genes can regulate methylation and affect the expression of other genes and are important in tumor and non-tumor diseases. Pieces of research on 7 NSUN family genes regarding methylation, diagnostic value, inflammatory diseases, cancer, and other diseases were searched for and summarized separately. Differences in NSUN family genes have been observed in many cancers, which can affect tumor growth, metastasis, chemotherapy resistance, and m5C methylation. In addition to affecting cancer, NSUN family genes have also attracted widespread attention due to their involvement in diseases related to growth, development, and metabolism. NSUN2 is the most studied NSUN family gene, which exhibits cancer promoting effects in various cancers such as lung cancer, liver cancer, and colorectal cancer. This review provides an overview of the roles of NSUN family genes in methylation, diagnostic value, inflammatory diseases, cancer, and other diseases.

1 January 2026 in Acta Cirurgica Brasileira
Verified
Journal Article
Open access
XLXiang Li
Xiang Li
JYJiangshun Yang
Jiangshun Yang
DFDengyang Fang
Dengyang Fang
WDWei Dai
Wei Dai
ZXZuming Xiong
Zuming Xiong
XCxuan chen
xuan chen
Purpose: We investigated the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) and combined them to create an inflammatory marker, the combined neutrophil-platelet score (CNPS), to serve as a diagnostic and predictive tool for complicated appendicitis. Methods: A retrospective analysis was conducted on the clinicopathological data of patients who underwent appendectomy. Receiver operating characteristic (ROC) curves and the area under the curve (AUC) were used to evaluate the diagnostic performance of various inflammatory parameters. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for complicated appendicitis. A prospective study was then carried out to validate the clinical utility of the CNPS. Results: In total, 322 patients were included in the retrospective analysis. Multivariate analysis identified only onset time and NLR as independent risk factors for complicated appendicitis, whereas the PLR was not. CNPS demonstrated superior diagnostic and predictive performance for complicated appendicitis compared to NLR and PLR. Moreover, after adjusting for confounders, CNPS remained an independent risk factor for complicated appendicitis. In the prospective study, 264 patients were included for analysis, and the AUC of CNPS for predicting complicated appendicitis was 0.707. Conclusion: The CNPS, combining NLR and PLR, demonstrates high diagnostic and predictive value for complicated appendicitis.

29 April 2023 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
JLJianxin Li
Jianxin Li
THTing Han
Ting Han
XWXin Wang
Xin Wang
YWYinchun Wang
Yinchun Wang
XCxuan chen
xuan chen
QYQingqiang Yang
Qingqiang Yang
Background. The long-term prognosis of gastric cancer (GC) remains poor due to postoperative recurrence and metastasis. The increasing evidence show that the lymph node ratio (LNR) serves as an independent prognostic factor in patients with GC. In this study, we aimed to develop a prognostic signature for GC based on LNR. Methods. Survival analysis was conducted by comparing low- and high-LNR groups according to the optimal cutoff value of LNR, which was identified by receiver operating characteristic (ROC) curve analysis. Then, we identified the differentially expressed genes (DEGs) related to LNR in the training cohort of GC. Univariate Cox regression and least absolute shrinkage and selection operator (LASSO) regression were performed to construct the risk score signature. We then evaluated the risk score signature from the viewpoints of survival, clinic-pathological characteristics, tumor microenvironment (TME), tumor mutation burden (TMB), and immunotherapeutic and chemotherapeutic efficacy. Results. High LNR was significantly correlated with poorer prognosis and was an independent predictor of recurrence in patients with GC. Then, an eleven-gene signature that could predict the prognosis of GC patients was developed based on LNR-related DEGs in the training cohort, and the results were further confirmed in external independent cohort. In addition, the high-risk group showed aggressive clinicopathological characteristics, specific TME status, low TMB, and low immunotherapeutic sensitivity. Conclusions. The present study constructed an eleven-gene prognostic signature based on LNR to predict the prognosis of patients with GC and facilitate the development of individualized treatment strategy.

15 July 2026 in Therapeutic Advances in Gastroenterology
Verified
Journal Article
Open access
XLXiang Li
Xiang Li
WDWei Dai
Wei Dai
XLXi Li
Xi Li
XCxuan chen
xuan chen
YCYajun Chen
Yajun Chen
JZJun Zhang
Jun Zhang
Background: Gastric cancer (GC) has high incidence and mortality rates worldwide, and lymph node metastasis (LNM) is a key determinant of prognosis and treatment strategy. Objectives: In this study, we aimed to investigate the association between eight inflammatory markers and LNM in GC and develop a prognostic model for LNM using inflammatory indicators. Design: This was a retrospective multicenter study. Methods: Clinical, pathological, and laboratory data from 868 GC patients were analyzed. Independent risk factors for LNM were identified through univariate logistic regression (LR), least absolute shrinkage and selection operator regression, and multivariable LR. Fourteen machine learning models were constructed using 10-fold cross-validation, and model performance was evaluated by calculation of the area under the receiver operating curve (AUC). Results: Five clinical and pathological characteristics were identified as independent risk factors for LNM in GC: Glasgow prognostic score (GPS), T stage, histological differentiation, vascular invasion, and total lymph node count. The categorical boosting (CatBoost) model demonstrated the best performance (AUC: 0.808) of all machine learning models tested, followed by the random forest model (0.806). Conversely, the AdaBoost model had the lowest AUC score (0.727). Further analysis of the CatBoost model showed that at the optimal threshold (0.56), it correctly identified approximately 82.7% of patients with LNM and approximately 69.4% of LNM-negative patients. Conclusion: These findings demonstrate the value of inflammatory markers, including the GPS, in prediction of LNM in patients with GC, as well as the ability of machine learning models to enhance prognostic accuracy, support informed treatment decisions, and improve patient outcomes.